Abilita Bio Inc.

Abilita Bio’s mission is to discover and develop transformative therapeutics by enabling drug discovery and development for intractable membrane protein (MP) targets, including G Protein-Coupled Receptors, Ion Channels and Transporters. Our proprietary Enabled Membrane Protein (EMP™) technology platform allows for the development of enhanced drug targets that will tranform the field of MP drug discovery and development.

Focus area
Platform / research tool
Commencement date
03/01/2015